An Intro To PrEP for HIV Prevention
In February 2016, Health Canada approved the use of daily Truvada as PrEP (Pre-Exposure Prophylaxis) for reducing the risk of transmission of HIV. Many people have not yet heard of PrEP, or if they have are not sure what to make of it. As well, many healthcare providers are unsure of how to proceed when a patient asks them about it.
Also - check out the new video of the "PrEP - The Pill to Prevent HIV: public information session" (scroll down to the bottom of this page) that took place on Jan. 31, 2018 at the Halifax Central Public Library. It was a great presentation and Q&A session with much valuable information shared.
So here’s some FAQs and resources to get started.
AUDIO: CBC Mainstreet interview promoting the Jan. 31st public info session on PrEP
ACNS's Prevention Coordinator Chris Aucoin and health research consultant San Patten are intereviewd.
VIDEO: PrEP - The Pill to Prevent HIV: public information session (Halifax, NS - 2018)
Join moderator Renée Masching, plus our panelists at the Paul O`Regan Hall of the Halifax Central Library. The event includes an introductory presentation, followed by an open Q&A taped on Jan. 31st, 2018.
The panel included: San Patten (Health Research Consultant); Dr. Matt Numer (Health Promotion Professor, Dalhousie University); Chris Aucoin (HIV Prevention Coordinator, AIDS Coalition of Nova Scotia); and Dr. Glenn Andrea (Medical Director, Dalhousie University Student Health & Wellness Centre).
This event was organized by the AIDS Coalition of Nova Scotia in partnership with the Nova Scotia PrEP Working Group, the Halifax Central Public Library, and the Nova Scotia Advisory Commission on AIDS.